Navigation Links
PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
Date:12/21/2011

is executive series to biopharmaceutical companies to assist them in determining paths forward to realize tangible results."

Attendees to the executive briefings will learn about how the delivery of best-practice outsourcing models can create significant value. The teams will review case studies showing how various relationship models--ranging from transactional and functional service approaches to preferred provider solutions and full strategic partnering-- have brought benefits to emerging and mid-size biopharmaceutical companies.

Leveraging its worldwide resources and technology infrastructure, PAREXEL has conducted clinical development programs on a global scale for clients across a broad range of therapeutic areas. The Company's vast investigator network, experience with various patient groups, and capacity to support innovative approaches to drug development can accelerate emerging and mid-size companies' efforts to deliver new medical treatments to the patients who need them. PAREXEL is well positioned to combine leading eClinical solutions with proven clinical processes to deliver meaningful operational improvements.  For more information about the range of capabilities PAREXEL brings together to assist companies of all sizes, visit:  http://www.PAREXEL.com/services-and-capabilities/.

About PAREXEL InternationalPAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical tri
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Closes the Acquisition of ClinPhone
2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
3. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
4. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
5. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
6. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
7. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
9. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
10. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
11. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...   Niagara Thermal Products is proud to announce ... LLC ("B3") as the critical thermal component supplier in ... Army Corps of Engineers.  B3 has developed the only ... and destroys VOCs and other chemical pollutants, allergens and ...
(Date:1/15/2014)... 15, 2014 Cynvenio, a cancer diagnostics ... the genomic analysis of tumor cells in the bloodstream, ... web-based cancer decision support application powered by CollabRx, Inc. ... ClearID™ genomic test, Therapy Finder will provide breast cancer ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... February 26 Arpida Ltd.,(SWX: ARPN) today reported that ... intravenous iclaprim in its first indication,complicated Skin and Skin ... weeks., Arpida has agreed with the U.S. Food ... rolling process. Using a ,rolling NDA, allows modules,within the ...
... Therapeutics,Inc. (Nasdaq: TPTX ) today announced that ... TorreyPines, will present at Susquehanna,Financial Group,s Second Annual ... on Tuesday, March 4th at 11:00 a.m., Eastern., ... be available live. You can,access the webcast at: ...
... BURLINGTON, Mass., Feb. 26 Hyaluron ... development,services, continued to expand its business in ... and staffing increasing greater than 60 percent ... HCM acquired,additional space at its Burlington MA ...
Cached Biology Technology:Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 2Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 3TorreyPines Therapeutics to Present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference 2HCM Announces Substantial Growth in 2007 2
(Date:7/10/2014)... centres around a family of enzymes known as heme ... in their active site. At the centre of the ... oxidised (ferryl) when a reacting heme is in an ... remained unanswered for decades is whether this oxidation involves ... (OH). Resolving this fundamental question has implications for understanding ...
(Date:7/10/2014)... New research from The University of Texas Health Science ... it Real (IYG), a health education program designed to ... significantly reduce dating violence behaviors among minority youth. , ... 10 percent of high school youth are victims of ... than 20 percent are victims of emotional dating violence. ...
(Date:7/10/2014)... Spanish National Cancer Research Centre (CNIO) Macromolecular Crystallography ... a protein called BuD to DNA in order ... Montoya, the researcher who led the study, says ... edit the instructions contained in the genome to ... The study is published in the journal ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3It's Your Game ... Keep It Real reduces dating violence among minority youth 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... sequenced an ancient RNA genome of a barley virus once ... back at least 2,000 years and revealing how intense farming at ... the University of Warwick have detected and sequenced the RNA genome ... found at a site near the River Nile in modern-day Egypt. ...
... Research UFZ present CLIMBER: Climatic niche characteristics ... on the climatic niche characteristics of 397 European butterflies ... provided in this dataset is of great relevance for ... high quality standards and open access, data ready to ...
... establish a state of the art Microbiorefinery (MBR) to ... Fossil fuel sources currently provide the basis for ... supplies and environmental considerations mean there is a growing ... The new facility, in collaboration with ...
Cached Biology News:RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 2RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 3Unique new dataset CLIMBER: Climatic niche characteristics of the butterflies in Europe 2University of Liverpool to establish microbiorefinery facility 2
... Degranulation, the secretion of cytoplasmic granules, ... inflammatory response of leukocytes (e.g. basophils, ... addition to histamine, these secretory granules ... cytokines, chemokines, and many proteases (Hallgren, ...
... Processing Service enables scientists who do not have ... software to have their biological samples tested for ... as easy as 1-2-3 Chose the ... samples from the S&S antibody menu. Send ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
... techniques are defined by the author of ... This valuable hardcover guide includes hundreds of ... references. More than 300 pages detail the ... preparation from selection and design of ...
Biology Products: